© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Co-Diagnostics, Inc. (CODX) shows an Average True Range (ATR) of 0.05 and an Enterprise Value of 23.71M. Its average trading volume over the past 3 months is 20.49M, indicating liquidity. These fundamental metrics provide insight into CODX's underlying financial health and market activity.
Co-Diagnostics, Inc. (CODX) technical indicators as of December 22, 2025: the SMA 20 is -20.72%, SMA 50 at -30.51%, and SMA 200 at -23.03%. The RSI 14 value is 39.62, suggesting its current momentum. These technical analysis signals help assess CODX's price trends and potential future movements.
Co-Diagnostics, Inc. (CODX) stock performance overview as of December 22, 2025: The 52-week high is $1.55 (currently -82.97% below), and the 52-week low is $0.228 (currently 16% above). Over the past year, CODX's performance is -68.28%, compared to the S&P 500's 12.87% change.
According to market data, Co-Diagnostics, Inc. (CODX) stock's recent performance metrics show that over the last month, CODX is -26.43%, with a Year-to-Date (YTD) performance of -64.81%. Over the past year, the stock has seen a -68.28% change. These figures summarize CODX's price movements across various periods, reflecting its historical returns.
According to current financial data, CODX stock's P/E (TTM) ratio is -0.31, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CODX, including P/S (17.59), P/B (0.25), and P/FCF (-0.28), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.